In search of an optimum dose escalation for narrowband UVB phototherapy: Is it time to quit 20% increments? - 09/08/11
Ankara, Turkey
Abstract |
Objectives |
Our aim was to compare 20% with 10% to 5% incremental regimens in narrowband UVB phototherapy.
Study patients |
The study included patients with psoriasis (N = 191) with Fitzpatrick skin phototypes II and III.
Results |
Occurrence of erythema as well as maximum and cumulative doses were higher with 20% escalations, whereas response rates and time to response did not significantly differ.
Limitations |
The study was limited by its retrospective nature.
Conclusion |
A 5% or 10% incremental regimen may have similar therapeutic efficacy.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. Conflicts of interest: None identified. |
Vol 55 - N° 2
P. 269-271 - août 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?